Appendix 4c Quarterly Activity Report for Quarter Ended March 31, 2024 | BioSpace

Chronic Low Back Pain – Phase 3 Program. Second Phase 3 trial underway for rexlemestrocel-L in the treatment of chronic low back pain (CLBP) due to …
Source: back pain